Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Persistent Bronchial Asthma”

40 trials

Showing 20 of 40 results

Large-scale testing (Phase 3)Study completedNCT00314574
What this trial is testing

Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)

Who this might be right for
Asthma
Genentech, Inc. 850
Post-approval studies (Phase 4)Study completedNCT00480649
What this trial is testing

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

Who this might be right for
Asthma
GlaxoSmithKline 424
Early research (Phase 1)Ended earlyNCT05035862
What this trial is testing

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

Who this might be right for
Asthma
Emory University 1
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Testing effectiveness (Phase 2)Study completedNCT01312961
What this trial is testing

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sanofi 104
Testing effectiveness (Phase 2)Study completedNCT00280683
What this trial is testing

Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

Who this might be right for
Asthma
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00096616
What this trial is testing

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 113
Large-scale testing (Phase 3)Study completedNCT00563056
What this trial is testing

An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

Who this might be right for
Asthma Bronchiale
Mundipharma Research Limited 227
Large-scale testing (Phase 3)UnknownNCT03387241
What this trial is testing

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Who this might be right for
Asthma
Mundipharma (China) Pharmaceutical Co. Ltd 330
Large-scale testing (Phase 3)Study completedNCT00529529
What this trial is testing

Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 805
Large-scale testing (Phase 3)Study completedNCT00163319
What this trial is testing

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

Who this might be right for
Asthma
AstraZeneca 500
Testing effectiveness (Phase 2)Study completedNCT01311661
What this trial is testing

Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 206
Not applicableStudy completedNCT07787507
What this trial is testing

Withania Somnifera for Moderate-to-Severe Persistent Asthma

Who this might be right for
Asthma
Aligarh Muslim University 120
Large-scale testing (Phase 3)Study completedNCT00476268
What this trial is testing

Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 824
Large-scale testing (Phase 3)Study completedNCT00599027
What this trial is testing

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

Who this might be right for
Allergic RhinitisAsthma
Organon and Co 51
Not applicableStudy completedNCT00282516
What this trial is testing

Asthma In-Home Monitoring (AIM) Trial

Who this might be right for
Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines
Tripler Army Medical Center 120
Large-scale testing (Phase 3)Study completedNCT01099722
What this trial is testing

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma

Who this might be right for
Asthma
Mundipharma Research Limited 261
Testing effectiveness (Phase 2)Study completedNCT00873860
What this trial is testing

Study to Evaluate the Safety and Efficacy of CAT-354

Who this might be right for
Asthma
MedImmune LLC 357
Post-approval studies (Phase 4)Study completedNCT00670930
What this trial is testing

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT00401596
What this trial is testing

Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)

Who this might be right for
Asthma
Genentech, Inc. 1,899
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation